Latest News & Features
Americas
The US Supreme Court has now heard arguments in the appeal of Teva v Sandoz from the US Court of Appeals for the Federal Circuit. This could fundamentally change how patent decisions are reviewed by the Federal Circuit and the deference given to district court rulings, says Felicia Boyd of Barnes & Thornburg. 27 November 2014
Americas
Google’s new contact lens sensor is just one of the latest eye-based devices that has vast potential in the field of medicine. LSIPR reports. 27 November 2014
Americas
The Supreme Court of Canada was expected to bring the Canadian law on utility more into line with other jurisdictions, but those hopes have now received a setback, as Gunars Gaikis of Smart & Biggar/Fetherstonhaugh reports. 27 November 2014
Asia
UK medical research charity MRC Technology has teamed up with Chinese pharmaceutical company Yabao as part of an effort to discover and develop treatments for Parkinson’s disease. 26 November 2014
Big Pharma
At first glance, it might seem odd for a company to both divide blood plasma and fight the side-effects of cancer treatment. But not for PlasmaTech Biopharmaceuticals, which tells LSIPR about how the company does it and also protects its IP. 26 November 2014
Americas
US pharmaceutical company Supernus Pharmaceuticals has sued Zydus Pharmaceuticals and Cadila Healthcare accusing them of infringing patents covering its antiepileptic drug, Trokendi XR (topiramate). 25 November 2014
Big Pharma
A new EU policy will require pharmaceutical companies to provide clinical trial data when seeking marketing approval for their drugs. But how will they ensure adequate IP protection while embracing the new culture of transparency? LSIPR reports. 25 November 2014
Americas
Steptoe & Johnson has added a partner to its New York IP team. 24 November 2014
Europe
A lawyer from GlaxoSmithKline has said the Unified Patent Court will take ten years to overcome teething problems. 20 November 2014
Americas
Indian drug maker Ranbaxy Laboratories has sued the US Food and Drug Administration and claimed it wrongfully revoked a previous approval for two new drugs. 19 November 2014